Avalon Nicole E, Murray Alison E, Daligault Hajnalka E, Lo Chien-Chi, Davenport Karen W, Dichosa Armand E K, Chain Patrick S G, Baker Bill J
Department of Chemistry, University of South Florida, Tampa, FL, United States.
Division of Earth and Ecosystem Sciences, Desert Research Institute, Reno, NV, United States.
Front Chem. 2021 Dec 24;9:802574. doi: 10.3389/fchem.2021.802574. eCollection 2021.
Complex interactions exist between microbiomes and their hosts. Increasingly, defensive metabolites that have been attributed to host biosynthetic capability are now being recognized as products of host-associated microbes. These unique metabolites often have bioactivity targets in human disease and can be purposed as pharmaceuticals. Polyketides are a complex family of natural products that often serve as defensive metabolites for competitive or pro-survival purposes for the producing organism, while demonstrating bioactivity in human diseases as cholesterol lowering agents, anti-infectives, and anti-tumor agents. Marine invertebrates and microbes are a rich source of polyketides. Palmerolide A, a polyketide isolated from the Antarctic ascidian is a vacuolar-ATPase inhibitor with potent bioactivity against melanoma cell lines. The biosynthetic gene clusters (BGCs) responsible for production of secondary metabolites are encoded in the genomes of the producers as discrete genomic elements. A candidate palmerolide BGC was identified from a microbiome-metagenome based on a high degree of congruence with a chemical structure-based retrobiosynthetic prediction. Protein family homology analysis, conserved domain searches, active site and motif identification were used to identify and propose the function of the ∼75 kbp -acyltransferase (AT) polyketide synthase-non-ribosomal synthase (PKS-NRPS) domains responsible for the stepwise synthesis of palmerolide A. Though PKS systems often act in a predictable co-linear sequence, this BGC includes multiple -acting enzymatic domains, a non-canonical condensation termination domain, a bacterial luciferase-like monooxygenase (LLM), and is found in multiple copies within the metagenome-assembled genome (MAG). Detailed inspection of the five highly similar BGC copies suggests the potential for biosynthesis of other members of the palmerolide chemical family. This is the first delineation of a biosynthetic gene cluster from an Antarctic microbial species, recently proposed as Synoicihabitans palmerolidicus. These findings have relevance for fundamental knowledge of PKS combinatorial biosynthesis and could enhance drug development efforts of palmerolide A through heterologous gene expression.
微生物群落与其宿主之间存在复杂的相互作用。越来越多的、过去被认为是宿主生物合成能力产生的防御性代谢产物,现在被认为是宿主相关微生物的产物。这些独特的代谢产物在人类疾病中往往具有生物活性靶点,可被用作药物。聚酮化合物是一类复杂的天然产物,通常作为防御性代谢产物,用于产生该化合物的生物体进行竞争或促进生存,同时在人类疾病中表现出生物活性,如作为降胆固醇药物、抗感染药物和抗肿瘤药物。海洋无脊椎动物和微生物是聚酮化合物的丰富来源。从南极海鞘中分离出的聚酮化合物帕默罗利德A是一种液泡型ATP酶抑制剂,对黑色素瘤细胞系具有强大的生物活性。负责次生代谢产物合成的生物合成基因簇(BGCs)在生产者的基因组中作为离散的基因组元件进行编码。基于与基于化学结构的逆生物合成预测的高度一致性,从微生物宏基因组中鉴定出一个候选帕默罗利德BGC。通过蛋白质家族同源性分析、保守结构域搜索、活性位点和基序鉴定,来识别并提出负责帕默罗利德A逐步合成的约75 kbp -酰基转移酶(AT)聚酮合酶-非核糖体合酶(PKS-NRPS)结构域的功能。尽管聚酮合酶系统通常以可预测的共线性序列起作用,但这个BGC包括多个起作用的酶结构域、一个非典型的缩合终止结构域、一种细菌荧光素酶样单加氧酶(LLM),并且在宏基因组组装基因组(MAG)中以多个拷贝形式存在。对五个高度相似的BGC拷贝的详细检查表明,帕默罗利德化学家族其他成员具有生物合成的潜力。这是首次从最近被提议为帕默罗利德氏共生菌的南极微生物物种中描绘出生物合成基因簇。这些发现对于聚酮合酶组合生物合成的基础知识具有重要意义,并可通过异源基因表达加强帕默罗利德A的药物开发工作。